AHF Hemophilia Disease Management Company Offers homedelivery of clotting factors and ancillary products for persons with hemophilia and related blood disorders. Explore its education and treatment programs. http://redirect-west.inktomi.com/click?u=http://www.looksmart.com/og/pr%3Dcdd%3B
Hemophilia Encyclopedia extensive overviews of key terms and concepts related to hemophilia and itstreatment. Nav Menu Home Patients Families hemophilia Encyclopedia. http://www.hemophiliagalaxy.com/1_PATIENTS/ENCYCLOPEDIA/
Extractions: Albumin is the most prevalent protein found in blood. It is used as a stabilizer in the manufacturing process of several factor VIII therapies. Albumin is used in the manufacture or formulation of every recombinant factor VIII product currently on the market or under clinical investigation. Antibody A protein produced by blood plasma cells that binds specifically to substances that the body recognizes as foreign. Once bound, the antibody can lead to the destruction or inactivation of the foreign substance. Inhibitors that occur in response to replacement therapies for hemophilia are antibodies to factor VIII Antihemophilic Factor (AHF)
Www.web-depot.com/hemophilia Similar pages hemophilia of Georgia Home Page This site is dedicated to providing information on the opportunities availablethrough hemophilia of Georgia for Georgia families who have hemophilia, von http://www.web-depot.com/hemophilia
Cell Genesys, Inc. Focused on the development and commercialization of cancer vaccines and gene therapies to treat various cancers including leukemia, hemophilia A and B, restenosis after angioplasty and Parkinson's disease. http://www.cellgenesys.com
Description of hemophilia. This page is intended for the general public, providinggeneralized information about coagulation. hemophilia Awareness Pages. http://www.hemophilia.net/descript.htm
World Federation Of Hemophilia FAQ Information and safety issues about blood collection, hemophilia, and blood products. http://www.wfh.org/ShowDoc.asp?Rubrique=28&Document=42
VersaPharm Pharmaceutical developer and marketer of specialty prescription products to the United States, working to develop and deliver pharmaceuticals primarily for treatment areas of Tuberculosis, hemophilia, and other blood disorders. http://www.versapharm.com/
Extractions: VersaPharm Incorporated develops and markets specialty prescription products to the United States: Pharmaceuticals for Tuberculosis, Hemophilia, Anthrax, STD, blood disorders and other diseases. By using this website, you agree to be bound by the Terms of Service and Purchase currently in effect. Click here to enter website
Hemophilia: What Is It? hemophilia link, DNA Learning Center Link, Concept 1 Children resembletheir parents. Learn how Mendel worked out inheritance in pea plants. http://www.yourgenesyourhealth.org/ygyh/mason/ygyh.html?syndrome=hemo
Your Genes, Your Health Offers a DNA Learning Center's multimedia guide to genetic, inherited disorders Fragile X syndrome, Marfan syndrome, cystic fibrosis and hemophilia are discussed in detail. http://www.yourgenesyourhealth.org
Tunnel For information in English, please go to this site Swedish hemophilia Society. http://www.xpress.se/fbis/english.html
MEDLINEplus Medical Encyclopedia: Factor V Deficiency Provides brief information about this inherited bleeding disorder, which is similar to hemophilia. Includes causes, symptoms, and prognosis. http://www.nlm.nih.gov/medlineplus/ency/article/000550.htm
Extractions: Skip navigation Other encyclopedia topics: A-Ag Ah-Ap Aq-Az B-Bk ... Z Contents of this page: Blood clot formation Blood clots Alternative names Return to top Parahemophilia; Owren's disease Definition Return to top Factor V deficiency is an inherited abnormal blood coagulation disorder caused by a deficiency of the plasma protein Factor V. Causes, incidence, and risk factors Return to top Normal blood coagulation is a complex process involving as many as 20 different plasma proteins , which are known as blood coagulation factors. A series of complex chemical reactions using these factors takes place very rapidly to form an insoluble protein called fibrin that stops bleeding When certain coagulation factors are deficient or missing, the chain reaction does not take place normally. Factor V deficiency is caused by inheriting a defective Factor V gene. In this disorder, bleeding ranges from mild to severe. The disease is similar to hemophilia , except bleeding into joints is less common. Bleeding can occur almost anywhere in the body, and death from hemorrhage has occurred with this disorder.
HEMOPHILIA A hemophilia A. DEFINITION 4. hemophilia with Factor VIIIc Inhibitors. massive dosesof Factor VIIIc concentrate; plasmapheresis with replacement of Factor VIIIc; http://www.icondata.com/health/pedbase/files/HEMOPHIL.HTM
Extractions: Please, take our 1 second survey! SEASONAL DEPRESSION MENTAL HEALTH ... WEIGHT LOSS Antihemophilic Factor (Human) (AHF), Hemofil M, Method M, Monoclonal Purified, is a sterile, nonpyrogenic, dried preparation of antihemophilic factor (Factor VIII, Factor VIII:C, AHF) in concentrated form with a specific activity range of 2 to 15 AHF International Units/mg of total protein. When reconstituted with the appropriate volume of diluent, it contains approximately 12.5 mg/mL Albumin (Human), 1.5 mg/mL polyethylene glycol (3350), 0.055 M histidine and 0.030 M glycine as stabilizing agents. In the absence of the added Albumin (Human), the specific activity is approximately 2,000 AHF International Units/mg of protein. It also contains, per AHF International Unit, not more than 0.1 ng mouse protein, 18 ng organic solvent (tri-n-butyl phosphate) and 50 ng detergent (octoxynol 9). See Clinical PHARMACOLOGY Hemofil M AHF is prepared by the Method M process from pooled human plasma by immunoaffinity chromatography utilizing a murine monoclonal antibody to Factor VIII:C, followed by an
HEMOPHILIA C Pediatric Database (PEDBASE); Discipline H O; Last Updated 8/28/93hemophilia C. DEFINITION A coagulation disorder characterized http://www.icondata.com/health/pedbase/files/HEMOPHI3.HTM
Comprehensive Hemophilia Treatment Center Specialty section of larger website provides detailed information on hemophilia conditions, describing available treatment programs for children and adults, procedures for contact. http://www.mcg.edu/centers/Hemo/index.html
Gene Therapy Website The Gene Therapy Program is located in the Department of Medicine and affiliated with the Stanley S. Scott Cancer Center and the Center for Human and Molecular Genetics at Louisiana State University Health Sciences Center at New Orleans. The major aim of the LSUHSC Gene Therapy Program is to develop new therapies for a series of genetic and acquired diseases including Cystic Fibrosis, hemophilia, Krabbes Disease and infectious diseases such as AIDS, TB, and pneumonia. http://www.medschool.lsumc.edu/GeneTherapy/Default.htm
Hemophilia Reports hemophilia Links. MRI Findings in Hemophilic Joints Treated With Radiosynoviorthesis.Anaerobic Power and Muscle Strength in Young Patients With hemophilia A. http://www.mmhc.com/hemo/